When was Exon Biosciences founded?

Exon Biosciences was founded in 2018.

Where is Exon Biosciences located?

Exon Biosciences is headquartered in Overland Park, United States.

How many employees does Exon Biosciences have?

As of Apr 30, 2026, the latest employee count at Exon Biosciences is 5.

Is Exon Biosciences a funded company?

Exon Biosciences is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Exon Biosciences rank among its competitors?

Exon Biosciences ranks 396th amongst 379 active competitors, of which 34 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Teknova, which secured $20.9M in Sep, 2023.

Who are the top competitors of Exon Biosciences?

Exon Biosciences' top competitors include Sino Biological, Miltenyi Biotec and Enzo. Among them, Teknova secured the most recent funding round in September, 2023.

Exon Biosciences - 2026 Company Profile, Team & Competitors

Company Details

Provider of reagent and kits for research solution. The company's products include reagents for DNA transfection, nucleic acid purification, cDNA purification. It also provides enzymes, kits and lyophilized master mix (Diamond Taq) for PCR, qPCR, and qRT-PCR.

Website: www.exonbiosciences.com
Social
Email ID: *****@exonbiosciences.com
Phone Number: +1 **********

Key Metrics

Founded Year

2018

Location

Overland Park, United States

Stage

Unfunded

Ranked

396^th among 464 competitors

Employee Count

5 as on Apr 30, 2026

Similar Companies

ArcherDX & 155 more

View Exon Biosciences' full profile

Exon Biosciences has not raised any funding rounds yet.

The founders of Exon Biosciences is Andrew Martin.

Here are the details of Exon Biosciences' key team members:

Andrew Martin: Founder of Exon Biosciences.

View details of Exon Biosciences's Founder profiles and Board Members

Exon Biosciences' employee count trend

Exon Biosciences has 5 employees as of Apr 26. Here is Exon Biosciences's employee count trend over the years:

Employee count trend for Exon Biosciences

Uncover Exon Biosciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Exon Biosciences include Sino Biological, Miltenyi Biotec and Enzo. Here is the list of Top 10 competitors of Exon Biosciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	65/100
2nd	Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised	Develops tools and products for research and clinical application	-	Europa, HHS	62/100
3rd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	60/100
4th	GenScript 2002, Piscataway (United States), Public	Provider of reagents and instruments for life sciences research	$15M	Kleiner Perkins, Vermögensclub & 1 others	59/100
5th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	58/100
6th	Teknova 1996, Hollister (United States), Public	Provider of molecular biology research reagents and kits	-	Telegraph Hill Partners, Europa	58/100
7th	ArcherDX 2013, Boulder (United States), Acquired	Developer of molecular cancer diagnostic products	$153M	Perceptive Advisors, PBM Capital & 8 others	58/100
8th	Promega 1978, Madison (United States), Funding Raised	Provider of genomics, protein analysis and expression, drug discovery, and genetic identification products	-	Venture Investors, NASA & 2 others	53/100
9th	BioIVT 1981, Westbury (United States), Acquired	Provider of in vitro diagnostic products and assay services	-	Thompson Street Capital Partners, Arsenal Capital Partners ... & 4 others	53/100
10th	ACD 2006, Newark (United States), Acquired	Developer of a transnational research platform for biomarker analysis	$39.4M	Summit Partners, Morningside & 5 others	52/100
396th	Exon Biosciences 2018, Overland Park (United States), Unfunded	Provider of reagent and kits for research solution	-	-	16/100